Literature DB >> 19224085

Monitoring and treatment practices of childhood asthma in Singapore: a questionnaire study.

C Tan1, B Wong, D Y Goh, H P Van Bever.   

Abstract

INTRODUCTION: Asthma is the most common chronic disease in children in Singapore. More than 20 percent of children will have been diagnosed with asthma by the age of 15 years. Most children are seen in the primary care setting, thus it is of value to study the management practices, especially of general practitioners, with comparison to gold standards. The aims of the study were to investigate: (a) Methods of monitoring asthma control; (b) Practices in managing acute exacerbations; and (c) Choice of therapy in maintenance treatment.
METHODS: 2,100 questionnaires consisting of 35 questions were sent by post to general practitioners and various paediatric doctors throughout Singapore. 173 valid responses were received and results were compared to the 2006 Global Initiative for Asthma guidelines.
RESULTS: 76.3 percent of respondents were general practitioners. 89.1 percent did not use symptom score cards / diaries. 37.6 percent did not use peak-flow meters / spirometers. 83.8 percent used a short-acting beta-agonist in acute exacerbations, but only 41.0 percent used oral corticosteroids in outpatients. A significant number used long-acting beta-agonists (LABA) in combination with inhaled steroids (29.5-41.6 percent) or as monotherapy (5.8-8.7 percent) for maintenance treatment. 91.3 percent never used immunotherapy in practice.
CONCLUSION: Greater usage of diaries / score cards can be encouraged along with objective peak flow / spirometry measurements. Management of acute exacerbations is appropriate but corticosteroids are under-prescribed by most doctors. LABA continues to be prescribed for maintenance despite a lack of established safety profile for infants, along with recommendations that they only be used selectively in patients poorly-controlled by medium-dosage inhaled corticosteroids.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224085

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  4 in total

1.  Cost considerations of therapeutic options for children with asthma.

Authors:  Sandra Chuang; Adam Jaffe
Journal:  Paediatr Drugs       Date:  2012-08-01       Impact factor: 3.022

2.  Wheeze in childhood: is the spacer good enough?

Authors:  Veena Rajkumar; Barathi Rajendra; Choon How How; Seng Bin Ang
Journal:  Singapore Med J       Date:  2014-11       Impact factor: 1.858

3.  Comment on: Monitoring treatment practices of childhood asthma in singapore: a questionnaire study.

Authors:  Julian Yaxley
Journal:  Singapore Med J       Date:  2016-02       Impact factor: 1.858

4.  Authors' reply: Comment on: Monitoring treatment practices of childhood asthma in singapore: a questionnaire study.

Authors:  Daniel Yam Thiam Goh; Hugo P Van Bever
Journal:  Singapore Med J       Date:  2016-02       Impact factor: 1.858

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.